Series A funding round for Octant Bio raising $30M in May 2020
Series A funding round for Octant Bio raising $30M in May 2020
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Sahil Lavingia |
| Angel | Drew Houston |
| Angel | Ryan Wyatt |
| Angel | Jiake Liu |
| Angel | Kevin Ding |
| Angel | Lev Ekster |
| Angel | Daren Cotter |
| Angel | Scott Belsky |
| Angel | Clark Landry |
| Angel | Scott Sandell |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$115M
Top Valuation
-
Octant Bio raised $30M in a Series A round.
The round was announced on 05/01/20.